---
title: "Neogen Chemicals Ltd (NEOGEN) — Share Price, Financials & Analysis"
symbol: "NEOGEN"
company: "Neogen Chemicals Ltd"
canonical: "https://tapetide.com/stocks/NEOGEN"
isin: "INE136S01016"
nse_symbol: "NEOGEN"
bse_code: "542665"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 6326.81
generated_at: "2026-09-13T18:46:33.906Z"
---

# Neogen Chemicals Ltd (NEOGEN)

Canonical page: https://tapetide.com/stocks/NEOGEN

## Company

- **NSE Symbol:** NEOGEN
- **BSE Code:** 542665
- **ISIN:** INE136S01016
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2019-05-08
- **CEO:** Dr. Harin Haridas Kanani Ph.D.
- **Employees:** 779
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** neogenchem.com

## About

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

## Latest Price

- **Price:** ₹2373
- **Change:** -15.9 (-0.67%)
- **Open:** ₹2390
- **Day High:** ₹2411
- **Day Low:** ₹2274.4
- **Previous Close:** ₹2388.9
- **Volume:** 409164
- **As Of:** 2026-09-11T10:20:03+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:16.763529Z.

- **Market Cap:** ₹6326.81 Cr
- **Classification:** Microcap
- **P/E (reported):** 183.7
- **P/E (TTM):** 179.09
- **EPS (TTM):** ₹13.25
- **EPS (reported):** ₹14.17
- **Book Value:** ₹356.91
- **Price to Book:** 6.69
- **Dividend Yield:** 0.04%
- **ROE:** 3.52%
- **ROCE:** 6.78%
- **Debt to Equity:** 1.71
- **Revenue (yearly):** ₹868.1 Cr
- **Net Income:** ₹28.8 Cr
- **EBITDA:** ₹143.4 Cr
- **52-Week High:** ₹2483.9
- **52-Week Low:** ₹966.7
- **RSI (14):** 68.1

## Tapetide Score

- **Score:** 32 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 3.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 19.57 | 9% |
| growth | 61.06 | 9% |
| momentum | 96.95 | 12% |
| ownership | 26.44 | 24% |
| quality | 39.8 | 22% |
| valuation | 9.41 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Promoter holding has increased by 1.78% over last quarter.
- Company's median sales growth is 20.3% of last 10 years
- Company's working capital requirements have reduced from 112 days to 84.6 days

### Weaknesses

- Stock is trading at 7.67 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 4.90% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 13.6% of profits over last 3 years
- Company has high debtors of 161 days.
- Promoter holding has decreased over last 3 years: -7.18%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -218.11% | -694.1% | — |
| ebitda margin growth | 16.48% | -7.97% | -1.84% | -7.97% |
| net income growth | 50% | -17.24% | -17% | -2% |
| revenue growth | 2.71% | 11.07% | 8% | 21% |
| roce | 18.14% | -30.32% | -33.2% | 11.06% |
| roe | 50.22% | -20.18% | 4.21% | -65.35% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 162 | 164 | 200 | 180 | 193 | 201 | 203 | 187 | 209 | 220 | 247 | 250 |
| Expenses | 136 | 144 | 164 | 149 | 159 | 167 | 166 | 155 | 179 | 188 | 203 | 202 |
| Operating Profit | 26 | 20 | 36 | 31 | 35 | 35 | 36 | 32 | 30 | 32 | 44 | 48 |
| OPM % | 16 | 12 | 18 | 17 | 18 | 17 | 18 | 17 | 14 | 14 | 18 | 19 |
| Other Income | 2 | 2 | 2 | 2 | 1 | 1 | -13 | 1 | 2 | 2 | 1 | 4 |
| Interest | 11 | 11 | 10 | 10 | 13 | 13 | 12 | 13 | 19 | 22 | 21 | 21 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 8 | 8 |
| Profit before tax | 11 | 6 | 22 | 16 | 15 | 15 | 4 | 14 | 5 | 6 | 16 | 23 |
| Tax % | 28 | 81 | 25 | 27 | 29 | 34 | 35 | 28 | 35 | 36 | 28 | 26 |
| Net Profit | 8 | 1 | 17 | 11 | 11 | 10 | 2 | 10 | 3 | 4 | 11 | 17 |
| EPS in Rs | 3.18 | 0.4 | 6.42 | 4.35 | 4.15 | 3.79 | 0.91 | 3.89 | 1.28 | 1.4 | 4.32 | 6.25 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 161 | 239 | 306 | 336 | 487 | 686 | 691 | 778 | 862 | 926 |
| Expenses | 132 | 196 | 248 | 272 | 401 | 575 | 581 | 641 | 725 | 772 |
| Operating Profit | 29 | 43 | 58 | 64 | 87 | 112 | 110 | 136 | 137 | 154 |
| OPM % | 18 | 18 | 19 | 19 | 18 | 16 | 16 | 18 | 16 | 17 |
| Other Income | 1 | 1 | 0 | 1 | 1 | 5 | 8 | -10 | 6 | 9 |
| Interest | 10 | 12 | 12 | 14 | 19 | 29 | 42 | 48 | 75 | 83 |
| Depreciation | 2 | 3 | 5 | 7 | 12 | 16 | 23 | 28 | 28 | 30 |
| Profit before tax | 17 | 29 | 41 | 44 | 57 | 71 | 53 | 50 | 41 | 50 |
| Tax % | 37 | 28 | 30 | 29 | 22 | 30 | 32 | 31 | 30 | — |
| Net Profit | 11 | 21 | 29 | 31 | 45 | 50 | 36 | 35 | 29 | 36 |
| EPS in Rs | 5.49 | 10.43 | 12.28 | 13.43 | 17.9 | 20.04 | 13.51 | 13.2 | 10.9 | 13.25 |
| Dividend Payout % | 18 | 14 | 16 | 17 | 15 | 15 | 15 | 8 | 18 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 20 | 20 | 20 | 23 | 23 | 25 | 25 | 26 | 26 | 26 |
| Reserves | 22 | 30 | 50 | 133 | 160 | 414 | 458 | 734 | 763 | 790 |
| Borrowings | 69 | 82 | 120 | 137 | 222 | 229 | 370 | 409 | 597 | 1395 |
| Other Liabilities | 41 | 48 | 56 | 61 | 87 | 131 | 202 | 292 | 361 | 691 |
| Total Liabilities | 152 | 180 | 246 | 355 | 492 | 799 | 1054 | 1461 | 1747 | 2902 |
| Fixed Assets | 56 | 67 | 83 | 111 | 127 | 285 | 347 | 496 | 404 | 475 |
| CWIP | 1 | 1 | 0 | 3 | 115 | 11 | 36 | 109 | 156 | 857 |
| Investments | 0 | 0 | 1 | 1 | 1 | 82 | 77 | 0 | 0 | 0 |
| Other Assets | 94 | 112 | 163 | 241 | 250 | 422 | 594 | 856 | 1187 | 1570 |
| Total Assets | 152 | 180 | 246 | 355 | 492 | 799 | 1054 | 1461 | 1747 | 2902 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 12 | -4 | -35 | 84 | 1 | -30 | -29 | 196 | -231 |
| Cash from Investing Activity | -33 | -13 | -20 | -29 | -135 | -146 | -94 | -216 | -317 | -410 |
| Cash from Financing Activity | 33 | 0 | 24 | 63 | 51 | 188 | 100 | 237 | 113 | 642 |
| Net Cash Flow | 1 | -1 | 0 | -1 | 0 | 44 | -25 | -8 | -8 | 0 |
| Free Cash Flow | -33 | -1 | -24 | -63 | -51 | -65 | -134 | -332 | -121 | -647 |
| CFO/OP | 21 | 55 | 4 | -38 | 146 | 13 | -17 | -18 | 153 | -154 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 107 | 94 | 93 | 90 | 85 | 82 | 94 | 149 | 94 | 161 |
| Inventory Days | 228 | 192 | 188 | 257 | 211 | 258 | 275 | 365 | 267 | 445 |
| Days Payable | 177 | 141 | 111 | 71 | 122 | 131 | 147 | 138 | 227 | 346 |
| Cash Conversion Cycle | 158 | 145 | 169 | 276 | 174 | 209 | 223 | 376 | 134 | 260 |
| Working Capital Days | 174 | 48 | 63 | 95 | 66 | 111 | 79 | 129 | 123 | 85 |
| ROCE % | 23 | 23 | 26 | 22 | 17 | 14 | 13 | 9 | 9 | 6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60.18% | 56.89% | 56.89% | 56.89% | 51.23% | 51.23% | 51.23% | 51.23% | 51.23% | 51.23% | 51.23% | 53.01% |
| FIIs | 4.24% | 4.51% | 4.56% | 4.65% | 8.17% | 7.73% | 7.79% | 7.36% | 5.15% | 4.57% | 4.46% | 4.11% |
| DIIs | 20.25% | 22.84% | 22.14% | 22.54% | 22.48% | 22.53% | 22.75% | 22.96% | 25.23% | 21.99% | 22.64% | 19.6% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.17% | 11.76% | 12.5% | 11.82% | 13% | 13.22% | 12.89% | 12.97% | 12.64% | 15.3% | 15.11% | 16.44% |
| Others | 4.16% | 3.99% | 3.91% | 4.1% | 5.13% | 5.29% | 5.35% | 5.48% | 5.75% | 6.9% | 6.56% | 6.85% |
| No. of Shareholders | 45300 | 47018 | 48356 | 46698 | 46470 | 47651 | 46104 | 46321 | 45710 | 47884 | 54332 | 61988 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 3 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2220.37 | Buy |
| EMA (10) | 2255.61 | Buy |
| SMA (20) | 2224.97 | Buy |
| EMA (20) | 2215.67 | Buy |
| SMA (50) | 2144.75 | Buy |
| EMA (50) | 2127.98 | Buy |
| SMA (100) | 1980.77 | Buy |
| EMA (100) | 1975.75 | Buy |
| SMA (200) | 1613.79 | Buy |
| EMA (200) | 1795.23 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 66.26 | Neutral |
| MACD (12,26,9) | 46.71 | Buy |
| Stochastic (14,3,3) | 84.09 | Sell |
| ADX (14) | 29.73 | Buy |
| Williams %R (14) | -11.71 | Sell |
| ATR (14) | 101.22 | High Volatility |
| ROC (12) | 8.69 | Buy |
| Stoch RSI (14) | 90.61 | Sell |
| UO (7,14,28) | 59.76 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 7 | 70% |
| Hold | 2 | 20% |
| Sell | 1 | 10% |

Based on 10 analyst ratings, observed at 2026-09-11T04:45:14.596339+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Qualified Institutional Placement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57b3ed22-e684-4411-9044-acf109034afb.pdf) |
| 2026-09-10 | [Outcome Of Fund Raising Committee Meeting Held Today](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b47118e-5760-48f4-a5c4-cb1eff5cabaa.pdf) |
| 2026-09-06 | [Disclosure Under Regulation 30 And 51(2) Read With Schedule III Of The SEBI LODR - Show Cause Cum Demand Notice](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d71a73f3-aa66-4676-b140-70f64a15ab29.pdf) |
| 2026-08-31 | [Disclosure Pursuant To Regulation 30 (9) Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f022ccc-32df-4edb-99da-0292854a45a8.pdf) |
| 2026-08-29 | [Disclosure Pursuant To Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07ff35fd-2d8d-48d7-86e8-f678c823a138.pdf) |
| 2026-08-22 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5015663-373f-4d62-8d53-a24720fdc3f2.pdf) |
| 2026-08-22 | [Submission Of Consolidated Voting Results And Scrutinizers Report Of The 37Th AGM.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed46dedf-88ea-4d6c-9f5d-ba974c5fcbe4.pdf) |
| 2026-08-21 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a54ab14-2004-4ac7-bf83-d7faed7fa45c.pdf) |
| 2026-08-20 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3522C209_4DB8_42EF_9433_260A42BDBFAB_104452.pdf) |
| 2026-08-20 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1F3A0507_F056_4234_8A19_8BAED5510A94_154531.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf8daf77-7548-48c1-85f3-bfa75a3d9126.pdf) |
| 2026-05-25 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4d82584-1599-424d-9a30-fcb41c2d752d.pdf) |
| 2026-02-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b19ba8db-b950-439e-af92-ebc2e7a392b3.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bf5e9c3-4698-488d-8d85-02d71761fc30.pdf) |
| 2025-08-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9234e6a-dbb5-454c-a0c5-ea30df54a25d.pdf) |
| 2025-05-26 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c53f2a44-3b45-40b4-bd9b-46ebd8bf589a.pdf) |
| 2025-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aed80596-85c0-4de3-8cf1-853403014abe.pdf) |
| 2024-11-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a600f839-33bb-431c-8635-49b62301ae99.pdf) |
| 2024-08-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d56a097-9ec1-441c-9ab6-85b45b038e56.pdf) |
| 2024-05-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6f00827-c5df-442f-b65c-95b101c6b226.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3229b4f4-92c9-4678-a962-fdba724bb459.pdf) |
| 2026-05-17 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90e19a1f-9382-4aaf-b903-86641320c6d1.pdf) |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e7a4a3d-e882-4fb8-be6a-211df436c27d.pdf) |
| 2025-11-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=565ce907-99c9-43df-9e37-4616a1f6c8a3.pdf) |
| 2025-08-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ce6fd00-ea19-43a3-840b-afdec74b24de.pdf) |
| 2025-05-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16675d65-d68b-463a-a3b3-10543c66f6ea.pdf) |
| 2025-02-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e90da0d4-4add-4f8e-afcb-a3e35da3b9c6.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec5f4a6e-b610-4cd7-ae9c-7cd546c3140d.pdf) |
| 2024-08-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35510c30-16bd-460c-86b5-49ec621eea99.pdf) |
| 2024-05-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a099f505-095b-4b2a-81f7-eeb3f938465a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-24 | [Financial Results For The Quarter Ended June 302026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e7055b2-4960-466d-b5fc-60f5c62f0358.pdf) |
| 2026-05-16 | [Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42800ba0-bd87-47af-8c5f-e1952a7de570.pdf) |
| 2026-02-11 | [Outcome Of Board Meeting Approving Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95e6d43e-bff7-459c-a74b-7e308ca4a8e9.pdf) |
| 2025-11-08 | [Outcome Of Board Meeting- Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66c45337-7ac5-444d-a33e-149769c44ada.pdf) |
| 2025-08-02 | [Results - Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58c54d33-4fa3-4e4a-b2d2-d32e2e2348b2.pdf) |
| 2025-05-17 | [Financial Results For Q4 And FY 2024-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca0ae6c-c4eb-47be-a09f-ed24fc0c5fbc.pdf) |
| 2025-02-01 | [Outcome Of Board Meeting- Financial Results For The Quarter Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea2fa629-ba94-413d-bfcf-8b23fae35617.pdf) |
| 2025-02-01 | [Financial Results For The Quarter Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2b658a1-d283-4027-a4de-b923b9035f82.pdf) |
| 2024-11-12 | [Unaudited Results For The Quarter Ended 30-09-2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da2a2634-a2bb-423f-b962-3b737ced273a.pdf) |
| 2024-04-30 | [Outcome Of Board Meeting And Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c275db52-afab-477f-85d3-d14b860b690f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2023 | [Concall - Sep 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1415fa92-bb3e-452a-b4b2-aca630a02198.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7bf5e9c3-4698-488d-8d85-02d71761fc30.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a600f839-33bb-431c-8635-49b62301ae99.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d017460d-af38-4bc7-81a8-9acacf044375.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4d82584-1599-424d-9a30-fcb41c2d752d.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f4d82584-1599-424d-9a30-fcb41c2d752d.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90e19a1f-9382-4aaf-b903-86641320c6d1.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/90e19a1f-9382-4aaf-b903-86641320c6d1.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd54fda1-3a52-4225-8a5b-54218f0710cb.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c53f2a44-3b45-40b4-bd9b-46ebd8bf589a.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Copy of newspaper publication - Notice of EGM. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Mar - Copy of newspaper publication - Notice of EGM.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f44d037-a22b-4c0b-a385-72eb192f0b3c.pdf) |
| 8h - Cadamba Solutions acquired 10 lakh Neogen shares via Rs161 crore preferential allotment on April 18, 2026. | [Announcement Under Regulation 30 Of SEBI LODR Regulations And 29(2) Of SEBI SAST Regulations 8h - Cadamba Solutions acquired 10 lakh Neogen shares via Rs161 crore preferential allotment on April 18, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/71ae962f-5c2e-4065-947a-176318774a3b.pdf) |
| 8h - Cadamba Solutions acquired 10 lakh Neogen shares via preferential allotment on April 18, 2026, for 161 crore. | [Announcement Under Regulation 30 Of SEBI LODR Regulations And Regulation 7(2) Of SEBI PIT Regulations 8h - Cadamba Solutions acquired 10 lakh Neogen shares via preferential allotment on April 18, 2026, for 161 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b332a792-df2a-492e-8116-12688834dea4.pdf) |
| 8h - Cadamba Solutions acquired 10 lakh Neogen shares via preferential allotment on April 18, 2026 for Rs 161 crore. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 8h - Cadamba Solutions acquired 10 lakh Neogen shares via preferential allotment on April 18, 2026 for Rs 161 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/F528BA36_16ED_4719_BAA3_285684D6C62E_192440.pdf) |
| 7 Mar - Preferential issue of 1,000,000 shares at Rs1,610 (Rs161 crore) to Cadamba Solutions; EGM March 29, 2026; record date March 20. | [Announcement under Regulation 30 (LODR)-Raising of Funds 7 Mar - Preferential issue of 1,000,000 shares at Rs1,610 (Rs161 crore) to Cadamba Solutions; EGM March 29, 2026; record date March 20.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b0f9b40-2b9c-4a14-88e7-6c4fc834656a.pdf) |
| 7 Mar - EGM on March 29, 2026 to approve preferential issue: 10,00,000 shares @Rs1,610 each (Rs161 crore) to Cadamba. | [Notice Of Extra Ordinary General Meeting 7 Mar - EGM on March 29, 2026 to approve preferential issue: 10,00,000 shares @Rs1,610 each (Rs161 crore) to Cadamba.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8972fb24-7608-499a-bf70-9d0f769a0e13.pdf) |
| 7 Mar - EGM on March 29, 2026 to approve preferential allotment of 10,00,000 shares at Rs1,610 each (Rs161 crore) to Cadamba Solutions | [Notice Of EGM And Other Timelines Including Book Closure Period. 7 Mar - EGM on March 29, 2026 to approve preferential allotment of 10,00,000 shares at Rs1,610 each (Rs161 crore) to Cadamba Solutions](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c345e78b-56ec-402f-bf52-663c676d4be9.pdf) |
| 30 Mar - EGM (Mar 29, 2026) approved preferential issuance of equity shares to promoter group member. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 30 Mar - EGM (Mar 29, 2026) approved preferential issuance of equity shares to promoter group member.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1621fd92-4b8a-4022-a252-7a0d23b18041.pdf) |
| 30 Apr - Promoter Dr. Harin Kanani disclosed pledge of 13,19,083 shares (5%) on March 30, 2026. | [Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 30 Apr - Promoter Dr. Harin Kanani disclosed pledge of 13,19,083 shares (5%) on March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0A9D979A_35F0_4CEA_8C52_859E7029D260_100650.pdf) |
| 30 Apr - Promoter Dr. Harin Kanani disclosed pledge of 13,19,083 shares (5%) on March 30, 2026. | [Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 30 Apr - Promoter Dr. Harin Kanani disclosed pledge of 13,19,083 shares (5%) on March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0A9D979A_35F0_4CEA_8C52_859E7029D260_100650.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d7ec3d3c-b9cd-41f1-840c-776f99a43ff3.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0f94492d-5f4e-4114-96b5-12a3fb45859e.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae675d3d-7c2a-4c44-960a-f23cd8ebbbb1.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-02-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16ccf638-3bbf-4503-bf5d-99405ebc03c0.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:46:33.906Z.